| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.17 | 8e-06 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.15 | 8e-06 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.17 | 1e-05 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | 0.17 | 1e-05 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | -0.18 | 1e-05 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | -0.17 | 1e-05 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | 0.18 | 1e-05 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.16 | 1e-05 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.16 | 2e-05 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.19 | 2e-05 |